LL Bioboost injectable supplement recalled for lack of sterility
Thrive Health Solutions is recalling LL Bioboost Injectable pre-filled syringes because the manufacturer cannot assure the product was manufactured under sterile conditions. Consumers should stop using the product and consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product—an injectable with unassured sterility—where no illnesses or injuries have been reported. The FDA Class II designation and the theoretical hazard of contamination via injection warrant a High severity rating.
Plain-English summary
Thrive Health Solutions, LLC is recalling LL Bioboost Injectable pre-filled syringes nationwide because the manufacturer cannot provide assurance that the product was manufactured under sterile conditions. This injectable product contains Methionine, Inositol, Choline Chloride, and Cyanocobalamin in sterile water for injection.
The affected product is identified by Lot #H277639 with an expiration date of June 2025. Approximately 64 syringes were distributed nationwide across the United States.
This recall affects anyone who has received this injectable product. The FDA has classified this as a Class II recall. Consumers who have this product should stop using it immediately and speak with their healthcare provider regarding their use of this product and any potential health concerns.
The recalled product
- Product
- LL Bioboost Injectable, Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, and Cyanocobalamin 1 mg in SWFI, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
- Manufacturer
- Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
- Category
- Drug — Injectable / Supplement
- Hazard
- sterility-assurance
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: H277639
- Exp 6/25/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27